Dr. Chantal Bader is the first candidate of the Young AcademiXX program at Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI) in cooperation with...
In the years of the COVID-19 pandemic, the effectiveness of government-ordered measures to contain the pandemic, such as regular testing and the wearing of medical masks, was repeatedly called into question. Through a...
At the Helmholtz Centre for Infection Research (HZI) in Braunschweig, four young scientists will start their work in late summer and fall 2024 to investigate resilience mechanisms of microbes and humans. As part of the...
The huge community of microorganisms in our gut keeps us healthy. And when things go wrong, we get sick. And not just a little: Disorders of our microbiome could be the trigger for morbid obesity, diabetes, inflammatory...
CRISPR-Cas systems, defense systems in bacteria, have become a plentiful source of technologies for molecular diagnostics. Researchers at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg have...
The lungs have a very complex structure, which makes it difficult to simulate them in the laboratory using human cell line models. As a result, researchers still rely on animal testing in preclinical studies to develop...
Prof Dr Fabian Leendertz Research Group Leader +49 3834-3916-101 E-Mail Fabian Leendertz studied veterinary medicine at the University of Budapest and the Freie Universität (FU) Berlin. In 2005, he became a doctor of veterinary…
